Medicine Information

Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bristol Myers


Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck's Vioxx and Pfizer's Bextra, two non-steroidal anti-inflammatory drugs (NSAIDs) that were voluntarily withdrawn from the market recently. Studies showed that they increase the likelihood of strokes and heart attacks among patients that take them for prolonged periods of time. This represents an unusual move for a pharmaceutical company, as they tend to spend a large portion of their annual advertising budget on direct-to-consumer advertising.

It is possible that Bristol Myers recognizes that consumers are becoming concerned about new drugs being approved by the FDA and advertised heavily, only to find out later that the drugs have previously unknown and possibly dangerous side effects. Consumers have learned that advertising a drug as "new and improved" doesn't necessarily mean that it is new, or improved, or even safe. In short, customers are suspicious of pharmaceutical advertising, and the drug companies are to be commended for taking notice of that fact.

Since 1997, drug companies have been allowed by U.S. law to advertise directly to consumers. This has led to an astonishing number of ads on television and radio, as consumers see ads showing one happy person after another. The ads suggest that the happiness shown is a result of the use of the product, and a voiceover quickly mumbles through the known, and sometimes lengthy, list of side effects. Patients are encouraged to speak with their doctor, and they have been doing so in record numbers. The problem, as Bristol Myers know realizes, is that consumers are well aware that the withdrawn Bextra and Vioxx were advertised as being safe. This has naturally led to a general suspicion of all advertised drugs, and Bristol Myers correctly sees that they could be the victims of a drug-company backlash, even if they didn't manufacture any of the withdrawn products.

This will probably save Bristol Myers a lot of money in the short term, as their advertising would have largely gone to waste. The Food and Drug Administration is taking steps to make sure that the drugs that reach the U.S. market are safe, and in time, the public will again become more trusting of pharmaceutical advertising. In the meantime, TV viewers will be spared from having to watch the sometimes-cryptic drug ads, which often prompt questions of "What does this drug do?"

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:

BG Medicine Announces Publication of Biomarker Signature of ...
MarketWatch - 4 hours ago
BG Medicine holds the exclusive world-wide license to the biomarker discovery reported in the article. "This two-marker biomarker set may provide an ...


Telegraph.co.uk

Medpedia Announced, World's Largest Collaborative Online ...
FOXBusiness - Jul 23, 2008
The Medpedia Project today announced the formation of the world's largest collaborative online encyclopedia of medicine called Medpedia. ...
Medpedia: Online Encyclopedia of Medicine Medgadget.com
Medpedia Aims To Be The Wikipedia Of The Medicine World E Canada Now
Medpedia Forms Online Medical Encyclopedia Site looking for ... EndoNurse
San Jose Mercury News - Computerworld
all 56 news articles


Ready for real Indian medicine?
ZDNet - 6 hours ago
From the same legal structure which brought you Harrah’s Cherokee Casino, a North Carolina entrepreneur wants to build hospitals. (This map of North Dakota ...


Growing number of primary-care doctors adopt concierge medicine
Arizona Republic, AZ - Jul 23, 2008
Concierge medicine is an appealing option for some primary-care doctors who want to break free from the assembly-line method of patient care that they say ...


The Associated Press

Booming business helps patients navigate medicine
The Associated Press - 8 hours ago
NORCROSS, Ga. (AP) — After three surgeries, Judy Sherer still had chronic pain in her left shoulder. She'd lost faith in her doctors, and in despair tried a ...


KARK

2:20 pm - UALR Scientist Named to Romanian Nano-Medicine Institute
KARK, Little Rock - 8 hours ago
The newly formed Romanian Nano-Medicine Institute has named Dr. Alex Biris (photo at left), chief scientist at the Nanotechnology Center at UALR, ...


BREAKING NEWS: JPS' Head Of Internal Medicine Pleads Guilty To ...
NBC5i.com, TX - 10 hours ago
Dr. James Shin, 46, of Southlake, also known as Young Jin Shin and James Young-Jin Shin, faces up to 10 years in prison, a $250000 fine and a lifetime of ...
Texas doctor pleads guilty in child porn case Houston Chronicle
Top JPS Doctor Pleads Guilty To Child Porn Charge CBS 11
Southlake doctor pleads guilty to possession of child pornography ... Dallas Morning News
Fort Worth Star Telegram
all 25 news articles


Tech Tools Will Change the Way Medicine Is Practiced
Talent Management, CA - 8 hours ago
However, the fundamental cultural changes that need to take place in medicine, lack of technology adoption and steep investment that must be made to fully ...


Personalized Medicine Coalition Announces Two New Board Members
FOXBusiness - Jul 23, 2008
The PMC, an educational and advocacy group dedicated to advancing the understanding and adoption of personalized medicine, was launched in 2004 by more than ...


Cricketnext.com

Asif seeks British medicine expert's help
Cricketnext.com, India - Jul 23, 2008
PTI Karachi: Pakistan's suspended pace bowler Mohammad Asif is trying to hire the services of renowned sports medicine expert from England Dr Graham Durgan ...

Medicine - Google News

home | site map
© 2006